Swedish BioTech Forum planned for November
The Karolinska Institute, together with the Swedish academy of pharmaceutical sciences, is organising BioTech Forum 2003, to take place from 26 to 28 November in Stockholm, Sweden.
Archives for July 14, 2003
ALA LabFusion springs from ISLAR ashes
This year's ISLAR meeting - the last ever to be held - will be replaced in 2004 by a new Association of Laboratory Automation conference called LabFusion.
Ambion launches first SARS control
RNA specialist Ambion has introduced what it claims is the first commercially available positive control for use in the detection of the SARS virus.
Celltech books long run at Lonza facility
Lonza Biotec is to manufacture PEGylated antibody fragment-based drugs for Celltech under the terms of a new agreement between the two companies. The two companies have also reached an agreement on a prior deal relating to Celltech's arthritis drug...
Amersham extends CyDye fluor range
Amersham Biosciences has added to its range of CyDye mono-reactive fluor dyes with two products used for labelling proteins or antibodies in protein array experiments.
Celsis wins long-term GSK contract
Celsis International, which specialises in microbial screening, has won a contract to provide its systems to GSK as a preferred supplier.
4SC and Esteve extend CNS project
A pilot project aimed at identifying new drug candidates for central nervous system disorders, initiated by Germany's 4SC and Spain's Esteve, has grown into a full-blown collaboration between the companies.
Crucell revenues slide in 2Q
Dutch biotechnology company Crucell has reported a decline in revenues for the second quarter of 2003, down 62 per cent to €1.1 million.
Plant compounds for cancer control
MolecularNature has forged a drug discovery partnership with Zetiq Technologies that has already yielded a number of novel cancer regulatory compounds.